MedTrace Logo

Comparison of ACT Between Hemochron Jr and ACT Plus

NCT02484157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2015-06-29

No results posted yet for this study

Summary

This study aimed to compare 2 activated clotting time analysers (Hemochron Jr vs. ACT Plus).

Conditions

  • Cardiac Disease

Interventions

DEVICE

Hemochron

Activated coagulation time was checked serially by Hemochron Jr.

DEVICE

ACT Plus

Activated coagulation time was checked serially by ACT Plus.

Sponsors & Collaborators

  • Hallym University Medical Center

    lead OTHER

Principal Investigators

  • Soo Kyung Lee, MD · Hallym University Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-12-31
Completion
2014-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02484157 on ClinicalTrials.gov